Clinical Trials Directory

Trials / Completed

CompletedNCT03663478

Continuous TQL Block for Elective Cesarean Section

Ultrasound-guided Transmuscular Quadratus Lumborum Catheters for Elective Caesarean Section. A Double Blind, Randomise, Placebo Controlled Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Zealand University Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate whether it is possible to prolong time to first opioid with the TQL block by inserting catheters bilaterally, providing continuous analgesia, in patients undergoing elective CS. Our hypothesis is that it will be possible to significantly extend time to first opioid with the blockade by 66.6%, increasing it from a mean of 5.6 hours to a mean of 10 hours.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine2 x 30 ml ropivacaine 0,2% and an elastomere pump with 200 ml ropivacaine 0,2%, infusion rate 8 ml/hour
DRUGSaline2 x 30 mL isotonic saline and an elastomere pump with 200 ml isotonic saline, infusion rate 8 ml/hour

Timeline

Start date
2018-09-04
Primary completion
2020-04-08
Completion
2020-04-08
First posted
2018-09-10
Last updated
2021-03-03

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03663478. Inclusion in this directory is not an endorsement.

Continuous TQL Block for Elective Cesarean Section (NCT03663478) · Clinical Trials Directory